Clicky

Ergomed(2EM)

Description: Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.


Keywords: Biotechnology Allergy Clinical Development Clinical Research Contract Research Organizations Pharmacovigilance Healthcare Quality Medical Information Services Pharmacovigilance Services Site Support Services

Home Page: www.ergomedplc.com

Surrey Research Park
Guildford, GU2 7HJ
United Kingdom
Phone: 44 1483 503 205


Officers

Name Title
Dr. Miroslav Reljanovic Founder & Exec. Chairman
Mr. Richard T. Barfield CFO & Exec. Director
Mr. Michael William Spiteri Chief Transformation & Technology Officer
Mr. Shaun Hopgood Chief Information Officer
Dr. Michael Forstner Head of Risk Management & Pharmacoepidemiology
Ms. Sally Amanuel Pres of PrimeVigilance
Dr. Gordana Tonkovic Pres of Clinical Research
Ms. Ronel Steyn Sr. VP of Global Devel.
Keith Byrne Sr. Vice-Pres of Capital Markets & Strategy
Jonathan Curtain Deputy CFO

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 26.3158
Trailing PE: 46.2759
Price-to-Book MRQ: 8.2764
Price-to-Sales TTM: 5.6343
IPO Date:
Fiscal Year End: December
Full Time Employees: 1371
Back to stocks